Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07696832

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally…

The treatment decisions, assessment schedule, and study procedures in this research will adhere to the routine clinical practice of each participating center. T…

China265 participantsStarted 2026-01-20Updated 2026-07-10

Treatment: Ivonescimab Injection

Patients Must Have Histologically or Cytologically Confirmed Locally Advanced or Metastatic NSCLC

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Efficacy and Safety of Ivonescimab Monotherapy as First-Line Treatment for PD-L1-Positive, Driver Gene-Negative, Locally…

All recent trials (1 shown)